| Name | Kynurenine Pathway Modulators for Neurodegeneration |
| Summary | Therapeutic strategies targeting the kynurenine pathway including IDO/TDO inhibitors, kynurenic acid augmentation, and quinolinic acid reduction for AD, PD, CBS, PSP, ALS, FTD, HD |
| Key Genes/Proteins | kynurenine aminotransferases, IDO1, SLC7A11 |
| Related Diseases | ferroptosis, cell_survival |
| Related Pathways | NAD_metabolism |
| Linked Hypotheses | 1 hypotheses |